Review Article
Intravenous Fluid of Choice in Major Abdominal Surgery: A Systematic Review
Table 9
Overview of randomized control trials related to return of bowel function by primary outcome.
| Author, year | Fluid compared | N | Operation | Conclusion |
| Primary outcome: return to bowel function, ileus, passing flatus, defecation, or enteral food tolerance | Yates [16], 2014 | Hartmann’s solution 6% HES 130/0.4 (Volulyte) | 202 | Colorectal surgery | No difference in bowel recovery time | Loffel [32], 2016 | Chloride-depleted glucose solution 5% (G5K) Ringer maleate | 44 | Cystectomy | G5K group could pass normal stool faster than RM (38 hours) | Ghodraty [22], 2017 | LRS 6% HES 130/0.4 (Voluven) | 91 | GI surgery | HES 130/0.4 reduced time of postoperative ileus (13 hours) |
| Primary outcome was another objective but also had these outcomes | Zhang [56], 2012 | Restricted-LRS (20) GD-LRS (20) GD-HES130/0.4 (20) | 60 | GI surgery | Goal-directed HES 130/0.4 reduced time to pass flatus (6 hours compared to restricted group and 9 hours compared to GD-LRS) |
|
|
HES = hydroxyethyl starch, LRS = lactated Ringer’s solution, GI = gastrointestinal, and GD = goal-directed therapy.
|